Nocturnal Hypertension

When and How to Use 24-h Ambulatory Blood PressureMonitoring in Patients with CKD

by Prateek Chopra | June 17, 2026 | Cardiology Conferences | ESH 2026 Study Background: Chronic kidney disease (CKD), defined as abnormalities of kidney structure or function persisting ≥3 months, is a growing global burden, ranking as the 10th leading cause of death and a major contributor to cardiovascular mortality. Hypertension is highly prevalent in CKD, and patients frequently exhibit true […]

When and How to Use 24-h Ambulatory Blood PressureMonitoring in Patients with CKD Read Post »

Leave a Comment / ESH Day 4 / / / , , , ,

Blood Pressure Variability: A Powerful Predictor of Cardiovascular and Cognitive Risk

by Prateek Chopra | June 2, 2026 | Cardiology Conferences | ESH 2026 Prognostic Significance of BP Variability: Blood pressure variability (BPV) is an important and modifiable cardiovascular risk marker beyond mean BP. Higher visit-to-visit systolic BP variability is linked to increased risks of CVD, stroke, heart failure, CKD, dementia, and all-cause mortality. Evidence: Clinical Implications: Monitoring and managing BP variability

Blood Pressure Variability: A Powerful Predictor of Cardiovascular and Cognitive Risk Read Post »

Leave a Comment / ESH Day 1 / / / , , , ,

Nocturnal Blood Pressure in Hypertension: Key Insights from the ESH 2026 Guidelines

by Prateek Chopra | June 1, 2026 | Cardiology Conferences | ESH 2026 Clinical Background: Nocturnal blood pressure (BP) assessment is critical for hypertension management and cardiovascular risk prediction. Elevated night-time BP is an independent risk factor for adverse cardiovascular outcomes, even in individuals with normal daytime BP. Nocturnal hypertension frequently coexists with obstructive sleep apnea (OSA), CKD, obesity, diabetes, autonomic

Nocturnal Blood Pressure in Hypertension: Key Insights from the ESH 2026 Guidelines Read Post »

Leave a Comment / ESH Day 1 / / / , , , ,
Scroll to Top